Dr Reddy’s Laboratories is looking to sharpen focus on biosimilars and innovation while continuing to fetch majority of revenues from generics and active pharmaceutical ingredients, said GV Prasad, co-chairman ...
Indian drugmaker Dr Reddy's Laboratories hopes to launch a generic version of Novo Nordisk's blockbuster weight-loss drug Wegovy at a competitive price that could be up to 60% lower ...
New Delhi: The division bench of the Delhi High Court on Friday refused to stay its single-judge order that allowed Dr Reddy's Laboratories to manufacture its version of diabetes ...
An expert committee has cleared Hyderabad-based drug major Dr Reddy’s Laboratories’ proposal to manufacture and market generic versions of blockbuster weight loss and obesity drug semaglutide.The company is aiming ...
Drugmakers Glenmark and Dr Reddy's Laboratories are recalling products in the US due to manufacturing issues, according to the US Food and Drug Administration (USFDA). As per its latest ...
Domestic drug majors Sun Pharma, Lupin and Dr Reddy's Laboratories are recalling drugs in the US market due to manufacturing issues and product mix up, according to the US ...
Last Updated:May 30, 2025, 21:01 ISTUnion Minister Jitendra Singh dubbed Revanth Reddy's remarks “hilarious” and said PoK would have existed "had Jawaharlal Nehru not been the PM of India".Union ...
Dr Reddy's Laboratories has received Form 483 with two observations after the US health regulator inspected its API manufacturing plant in Telangana. The US Food & Drug Administration (USFDA) ...
Dr Reddy’s Laboratories (DRL) share price plunged 6.66 per cent to Rs 1,203.50 per share on the NSE during Friday after analysts remained cautious on the company’s Q3 performance ...